Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-008538
Filing Date
2019-02-08
Accepted
2019-02-08 16:33:25
Documents
1
Period of Report
2019-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10235
  Complete submission text file 0001209191-19-008538.txt   11583
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139
Business Address
Arbuckle Stuart A (Reporting) CIK: 0001557290 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 19580409